These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition. Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872 [TBL] [Abstract][Full Text] [Related]
4. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo. Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis. Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057 [TBL] [Abstract][Full Text] [Related]
7. The polysaccharide fraction of Propionibacterium acnes modulates the development of experimental focal segmental glomerulosclerosis. Reis VO; Silva JC; Souza GT; Semedo P; Buscariollo B; Pereira RL; Cenedeze MA; Pacheco-Silva A; Longo-Maugéri IM; Câmara NO; Keller AC Immunobiology; 2012 Sep; 217(9):831-41. PubMed ID: 22257707 [TBL] [Abstract][Full Text] [Related]
8. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression. Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525 [TBL] [Abstract][Full Text] [Related]
9. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis. Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022 [TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Li Y; Kang YS; Dai C; Kiss LP; Wen X; Liu Y Am J Pathol; 2008 Feb; 172(2):299-308. PubMed ID: 18202193 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy. Nishad R; Mukhi D; Tahaseen SV; Mungamuri SK; Pasupulati AK J Biol Chem; 2019 Nov; 294(44):16109-16122. PubMed ID: 31511328 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kang YS; Li Y; Dai C; Kiss LP; Wu C; Liu Y Kidney Int; 2010 Aug; 78(4):363-73. PubMed ID: 20505657 [TBL] [Abstract][Full Text] [Related]
13. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy. Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098 [TBL] [Abstract][Full Text] [Related]
14. Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. Zhang B; Xie S; Shi W; Yang Y Nephrol Dial Transplant; 2012 May; 27(5):1746-55. PubMed ID: 22076430 [TBL] [Abstract][Full Text] [Related]
15. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling. Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144 [TBL] [Abstract][Full Text] [Related]
16. Podocyte injury at young age causes premature senescence and worsens glomerular aging. Veloso Pereira BM; Zeng Y; Maggiore JC; Schweickart RA; Eng DG; Kaverina N; McKinzie SR; Chang A; Loretz CJ; Thieme K; Hukriede NA; Pippin JW; Wessely O; Shankland SJ Am J Physiol Renal Physiol; 2024 Jan; 326(1):F120-F134. PubMed ID: 37855038 [TBL] [Abstract][Full Text] [Related]
17. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis. Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861 [TBL] [Abstract][Full Text] [Related]
19. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases. Szabó T; Ambrus L; Zákány N; Balla G; Bíró T Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740 [TBL] [Abstract][Full Text] [Related]
20. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]